
Acetylresorcinol
Resorcinol monoacetate is a member of the class of phenols that is resorcinol in which one of the phenolic hydroxy groups has been converted into its acetate ester. It has keratolytic properties and has been used for the treatment of acne. It has a role as an antibacterial agent and a dermatologic drug. It is a member of phenyl acetates and a member of phenols. It is functionally related to a resorcinol. — ChEBI
- Nom IUPAC
- (3-hydroxyphenyl) acetate
- Formule moléculaire
- C8H8O3
- Masse moléculaire
- 152.15 g/mol
- Masse exacte
- 152.047344113 Da
- XLogP3
- 1,3
- Surface polaire topologique
- 46,5 Ų
- Donneurs de liaisons hydrogène
- 1
- Accepteurs de liaisons hydrogène
- 3
- Unités covalentes
- 1
- Stéréocentres définis
- 0
Également connu sous le nom de
16 autres noms signalés
Identifiants de bases de données externes
- ChEBI:CHEBI:29672
- ChEMBL:CHEMBL1593874
- EPA DTXSID:DTXSID6045901
- PubMed:20383916
- PubMed:20339589
- PubMed:15866873
- PubMed:9543
Preuves issues de bases de données scientifiques complémentaires
EMBL-EBI ChEBI
resorcinol monoacetate
A member of the class of phenols that is resorcinol in which one of the phenolic hydroxy groups has been converted into its acetate ester. It has keratolytic properties and has been used for the treatment of acne.
- Formule
- C8H8O3
- Masse moyenne
- 152.149 g/mol
- Masse monoisotopique
- 152.04734 Da
- Charge formelle
- 0
- phenols — is a (CHEBI:33853)
- phenyl acetates — is a (CHEBI:140310)
- antibacterial agent — has role (CHEBI:33282)
- dermatologic drug — has role (CHEBI:50177)
- resorcinol — has functional parent (CHEBI:27810)
- antibacterial agent — has role (CHEBI:33282)
- dermatologic drug — has role (CHEBI:50177)
- phenols — is a (CHEBI:33853)
- phenyl acetates — is a (CHEBI:140310)
Noms supplémentaires validés
Références croisées de cette source
Mis en correspondance par: Exact CAS cross-reference in the ChEBI compound record. Source mise à jour le: 2020-04-28. Récupéré le: 2026-08-31. Ouvrir la fiche source
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Note: This chemical does not meet GHS hazard criteria for 47.4% (37 of 78) of reports. Source: European Chemicals Agency (ECHA)
- Signal: Danger Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (52.6%): Harmful if swallowed [Warning Acute toxicity, oral]; H317 (51.3%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H318 (51.3%): Causes serious eye damage [Danger Serious eye damage/eye irritation] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P272, P280, P301+P317, P302+P352, P305+P354+P338, P317, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 78 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 37 of 78 reports by companies.; There are 3 notifications provided by 41 of 78 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source
Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.
Couverture des sources complémentaires et état des correspondances
| Source | Résultat | Vérifié |
|---|---|---|
| EMBL-EBI ChEBI | Correspondance exacte | 2026-08-31 |
| NIH PubChem PUG-View | Correspondance exacte | 2026-08-31 |
Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.
Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.